
("Premier" or the "Company")
Director / PDMR shareholding
As announced on
Following the admission of the Settlement Shares to trading AIM,
The person who arranged the release of this announcement on behalf of the Company was Godfrey Manhambara.
Enquiries:
|
|
Tel: +27 (0) 100 201 281 |
|
(Nominated Adviser) |
Tel: +44 (0) 20 7628 3396 |
|
|
Tel: +44 (0) 20 3003 8632 |
|
|
Tel: +44 (0) 20 7408 4090 |
|
|
Tel: +44 (0)20 3005 5000 |
Nominated Adviser Statement
Beaumont Cornish Limited ("Beaumont Cornish"), which is authorised and regulated in the
Notes to Editors:
The Company has a diverse portfolio of projects, which include tungsten, rare earth elements, lithium and tantalum in
APPENDIX
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
|
|
||||
2
|
Reason for the notification |
|||||
a)
|
Position/status |
Chief Executive |
||||
b)
|
Initial notification /Amendment
|
Initial Notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a)
|
|
|
||||
b)
|
LEI
|
213800WDKYXYJZE5DZ61 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a)
|
Description of the financial instrument, type of instrument |
Ordinary shares of no-par value in
|
||||
|
|
|||||
Identification code |
ISIN: VGG7223M1005 |
|||||
|
|
|||||
b)
|
Nature of the transaction
|
Issue of Ordinary Shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d)
|
Aggregated information |
|
||||
|
|
|||||
- Aggregated volume |
N/A (single transaction) |
|||||
|
|
|||||
- Price |
|
|||||
|
|
|||||
e)
|
Date of the transaction
|
28/07/2025 |
||||
f)
|
Place of the transaction
|
AIMX |
Ends
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the